A. Welter

Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer

G. Bauerschmitz, T. Schöndorf, W. Janni, 2011, Journal of Cancer Research and Clinical Oncology.

Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancer.

T. Schöndorf, W. Janni, J. Volkmer, 2012, Oncology letters.

Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group

C. Garbe, E. Stockfleth, D. Nashan, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.